Psychedelic investments? (Patreon)

Wow, things really seem to be moving fast, the business world is already anticipating a "flood of investment" in psychedelics, those that get in early probably benefitting most.  As early enthusiasts, we should pay attention to potential opportunities.  ATAI, who just raised $40 million and is valued at nearly a quarter billion $ is currently funding clinical trials for what it refers to as “formerly stigmatized compounds,” including psilocybin, the active compound in psychedelic mushrooms.  ATAI is also the largest investor in a start-up called Compass Pathways, which is setting itself up to be the first legal provider of psilocybin. ATAI invested alongside Peter Thiel, the iconoclastic Silicon Valley investor and Facebook board member who’s increasingly dabbling in health and biotech.

"Biotech investors believe that psychedelic medicine will experience a revival in the wake of recent research studies as well as some early signals of support from regulators."  Last year, for example, the U.S. Food and Drug Administration (FDA) gave Compass a “Breakthrough Therapy ” designation for its research into psilocybin for depression, allowing legal clinical trials to start. “A decision (like that) by FDA is the ultimate signal for investors,” said Brad Loncar, a biotech investor with Loncar Investments, who specializes in cancer and rare disease. “It shows that there’s a regulatory path forward for this class of drugs, which typically causes a flood of investment in the area.”

I will be doing multiple videos on both psilocybin and psychedelic medicine.  Speaking of videos, the "Harmaline to THH reduction" video is almost finished, all video has been assembled and edited, I am just finishing up the audio track, should be published in the next few days.